News | March 16, 2012

Canada Clears Boston Scientific’s Blazer Open-Irrigation Ablation Catheter

March 16, 2012 — Boston Scientific Corp. announced Health Canada approval of the Blazer open-irrigated catheter, the company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as atrial fibrillation (AF), atrial flutter, ventricular tachycardia and other supraventricular tachycardias. The product will be launched immediately in Canada.

The Blazer open-irrigated catheter integrates Total Tip Cooling design with the high-performance Blazer catheter platform. The Total Tip Cooling design consistently cools the entire tip electrode during radiofrequency (RF) energy delivery, resulting in reduced coagulum at the proximal edges of the tip. This is achieved through both internal cooling and external washing of the tip electrode.

"The excellent cooling profile, coupled with the high performance Blazer platform, makes this catheter an important additional option for performing simple and complex ablations," said Felix Ayala-Parades, M.D., chief electrophysiologist at Sherbrooke University Hospital Centre in Quebec, who performed the first procedure in Canada using the Blazer open-irrigated catheter with Santiago Rivera, M.D. "The tip temperatures were lower than conventional open-irrigated catheters during RF delivery. The catheter handling also allowed for a smooth drag lesion to be created without any gaps in the lesion set and with good contact to ensure adequate lesion creation."

AF is a rapid irregular rhythm affecting the upper chambers of the heart. Patients are most often treated with anti-arrhythmic drugs, which can be associated with adverse side effects. Cardiac ablation with an radiofrequency ablation (RFA) catheter is being used increasingly for patients who cannot tolerate these medications.

"The Health Canada approval and launch of the Blazer open-irrigated catheter in Canada are important milestones in our continued focus on advancing cardiac ablation technology," said Hank Kucheman, CEO of Boston Scientific. "We are committed to expanding our Canadian electrophysiology business and improving outcomes for patients undergoing cardiac ablation procedures."

In the United States, the blazer open-irrigated catheter is an investigational device, limited by applicable law to investigational use only and not available for sale. The product is approved for use in CE mark countries.

For more information:

Related Content

Stereotaxis Receives Regulatory Approval of e-Contact Module in Canada
Technology | Ablation Systems | December 08, 2017
December 7, 2017 — Stereotaxis Inc.
CardioFocus Announces European CE Mark Approval of HeartLight Excalibur Balloon
Technology | Ablation Systems | October 10, 2017
October 10, 2017 — CardioFocus Inc. recently announced the European CE Mark approval of the HeartLight Excalibur Ball
The Apama Radiofrequency (RF) Balloon Catheter System.
News | Ablation Systems | October 02, 2017
October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems | August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems | July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biosense Webster multi-electrode RF ablation balloon

Biosense Webster's multi-electrode RF ablation balloon with irrigation. The system allows operators to change the energy levels of each electrode to avoid damaging sensitive underlying critical structures like the esophagus or phrenic nerve.

Feature | Ablation Systems | May 17, 2017 | Dave Fornell
May 17, 2017 – Clinical trial results from a first-in-human study evaluating the acute feasibility of an investigatio
Abbott Announces CE Mark for New Cardiac Ablation Catheter
News | Ablation Systems | May 10, 2017
Abbott announced CE Mark of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, developed to make it easier...
Medtronic, expanded indication, Freezor Xtra Cryoablation Catheter, AVNRT, atrioventricular nodal re-entrant tachycardia
Technology | Ablation Systems | February 16, 2017
Medtronic plc announced the U.S. Food and Drug Administration (FDA) has approved its Freezor Xtra Cryoablation Catheter...
CardioFocus, HeartLight Excalibur Balloon, 22nd Annual AF Symposium, atrial fibrillation, initial clinical evaluation
News | Ablation Systems | January 25, 2017
CardioFocus Inc. recently announced the initial clinical evaluation of the HeartLight Excalibur Balloon, a next-...
catheter ablations, atrial fibrillation, stroke risk, Intermountain Medical Center Heart Institute study, AHA Scientific Sessions, American Heart Association
News | Ablation Systems | November 14, 2016
Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation lower their long-term risk of...
Overlay Init